QC
CELG

QCM Cayman’s Celgene Corp CELG Stock Holding History

QCM Cayman’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,800
Closed -$846K – 497
2017
Q1 		$846K Buy
+6,800
New +$814K 0.16% 147
2016
Q4 		– Sell
-7,300
Closed -$763K – 289
2016
Q3 		$763K Buy
+7,300
New +$790K 0.84% 24
2014
Q4 		– Sell
-3,700
Closed -$351K – 339
2014
Q3 		$351K Buy
3,700
+1,200
+48% +$108K 0.08% 101
2014
Q2 		$215K Sell
2,500
-23,700
-90% -$1.8M 0.1% 181
2014
Q1 		$1.83M Buy
+26,200
New +$2.07M 0.41% 36
2013
Q4 		– Sell
-2,800
Closed -$216K – 207
2013
Q3 		$216K Buy
+2,800
New +$196K 0.13% 151

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM Cayman's CELG Position: Q3 2018 in Review

QCM Cayman sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 4,691 shares — an estimated $373K sold.

QCM Cayman first reported a position in CELG in Q1 2014 and held it in 4 quarters. The position peaked at $1.49M in Q2 2016. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • QCM Cayman reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • QCM Cayman sold 4,691 Celgene Corp shares in Q3 2018, an estimated $373K.
  • QCM Cayman first reported a position in Celgene Corp in Q1 2014 and held it in 4 quarters.
  • QCM Cayman's Celgene Corp position peaked at $1.49M in Q2 2016.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on QCM Cayman's 13F filing for Q3 2018, filed 14 Nov 2018.